Tower View Wealth Management’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $179K | Buy |
1,391
+10
| +0.7% | +$1.17K | 0.08% | 69 |
|
|
2026
Q1 | $166K | Buy |
1,381
+10
| +0.7% | +$1.15K | 0.09% | 68 |
|
|
2025
Q4 | $144K | Buy |
1,371
+13
| +1% | +$1.22K | 0.07% | 66 |
|
|
2025
Q3 | $114K | Buy |
1,358
+13
| +1% | +$1.07K | 0.06% | 69 |
|
|
2025
Q2 | $106K | Buy |
1,345
+13
| +1% | +$1.03K | 0.06% | 80 |
|
|
2025
Q1 | $120K | Buy |
1,332
+11
| +0.8% | +$1.03K | 0.07% | 60 |
|
|
2024
Q4 | $131K | Buy |
1,321
+3
| +0.2% | +$309 | 0.07% | 64 |
|
|
2024
Q3 | $150K | Buy |
1,318
+3
| +0.2% | +$356 | 0.08% | 60 |
|
|
2024
Q2 | $163K | Buy |
1,315
+2
| +0.2% | +$258 | 0.09% | 57 |
|
|
2024
Q1 | $173K | Buy |
1,313
+3
| +0.2% | +$370 | 0.1% | 62 |
|
|
2023
Q4 | $143K | Buy |
1,310
+3
| +0.2% | +$311 | 0.09% | 59 |
|
|
2023
Q3 | $135K | Buy |
1,307
+899
| +220% | +$96.9K | 0.09% | 60 |
|
|
2023
Q2 | $47K | Buy |
408
+3
| +0.7% | +$341 | 0.03% | 79 |
|
|
2023
Q1 | $43K | Hold |
405
| – | – | 0.03% | 83 |
|
|
2022
Q4 | $45K | Buy |
405
+2
| +0.5% | +$204 | 0.03% | 85 |
|
|
2022
Q3 | $35K | Buy |
403
+3
| +0.8% | +$268 | 0.03% | 88 |
|
|
2022
Q2 | $36K | Hold |
400
| – | – | 0.03% | 88 |
|
|
2022
Q1 | $33K | Hold |
400
| – | – | 0.02% | 114 |
|
|
2021
Q4 | $31K | Hold |
400
| – | – | 0.02% | 115 |
|
|
2021
Q3 | $30K | Sell |
400
-3,526
| -90% | -$268K | 0.02% | 122 |
|
|
2021
Q2 | $305K | Sell |
3,926
-302
| -7% | -$22.5K | 0.15% | 76 |
|
|
2021
Q1 | $311K | Sell |
4,228
-36,592
| -90% | -$2.7M | 0.17% | 78 |
|
|
2020
Q4 | $3.19M | Buy |
40,820
+1,623
| +4% | +$124K | 1.81% | 24 |
|
|
2020
Q3 | $3.1M | Buy |
39,197
+957
| +3% | +$75K | 2.02% | 20 |
|
|
2020
Q2 | $2.82M | Buy |
38,240
+3,549
| +10% | +$267K | 2.06% | 19 |
|
|
2020
Q1 | $2.55M | Buy |
34,691
+1,882
| +6% | +$148K | 2.3% | 16 |
|
|
2019
Q4 | $2.85M | Buy |
32,809
+277
| +0.9% | +$22.8K | 2.16% | 17 |
|
|
2019
Q3 | $2.61M | Buy |
32,532
+846
| +3% | +$67.8K | 2.16% | 20 |
|
|
2019
Q2 | $2.54M | Buy |
31,686
+470
| +2% | +$36K | 2.16% | 19 |
|
|
2019
Q1 | $2.48M | Buy |
31,216
+1,296
| +4% | +$96.9K | 2.2% | 21 |
|
|
2018
Q4 | $2.18M | Buy |
29,920
+25,581
| +590% | +$1.81M | 2.25% | 16 |
|
|
2018
Q3 | $294K | Buy |
4,339
+2,405
| +124% | +$153K | 0.26% | 62 |
|
|
2018
Q2 | $112K | Hold |
1,934
| – | – | 0.11% | 71 |
|
|
2018
Q1 | $100K | Hold |
1,934
| – | – | 0.1% | 73 |
|
|
2017
Q4 | $104K | Buy |
+1,934
| New | +$107K | 0.1% | 76 |
|
Other funds holding MRK
ATO
Tower View Wealth Management's MRK Position: Q2 2026 in Review
Tower View Wealth Management increased its Merck (MRK) stake by 0.72% in Q2 2026, buying an estimated $1.17K and bringing the position to 1,391 shares worth $179K. The position accounts for 0.08% of the portfolio, ranked #69.
Tower View Wealth Management first reported a position in MRK in Q4 2017 and has held it in 35 quarters since. The position peaked at $3.19M in Q4 2020. 1,549 funds tracked by Wall St. Rank hold MRK as of Q2 2026.
- Tower View Wealth Management held 1,391 shares of Merck worth $179K as of Q2 2026.
- Tower View Wealth Management bought 10 Merck shares in Q2 2026, an estimated $1.17K.
- Merck made up 0.08% of Tower View Wealth Management's portfolio in Q2 2026, its #69 holding.
- Tower View Wealth Management first reported a position in Merck in Q4 2017 and has held it in 35 quarters since.
- Tower View Wealth Management's Merck position peaked at $3.19M in Q4 2020.
- 1,549 funds tracked by Wall St. Rank held Merck as of Q2 2026.
Based on Tower View Wealth Management's 13F filing for Q2 2026, filed 24 Jul 2026.